Reflections from the 2025 ERA Congress: Insights on the Future of Kidney Research
Representatives from Medpace’s medical and operational teams engaged in critical discussions around trial innovation, therapeutic advances, and evolving standards of...
Highlights and Innovations from the 2024 ERA Congress
In May 2024, Medpace nephrology medical and operational experts attended the 61st ERA (European Renal Association) Congress in Stockholm, Sweden....
[Webinar] Chronic Kidney Disease: Breaking Barriers with Cardiovascular and Renal Integration in Clinical Trials
Register now for this upcoming webinar on July 25th at 11:00am EDT, in which featured speakers from Medpace share integrated approaches to include patients with…
Medpace Expands Medical Leadership in Nephrology
Medpace is pleased to announce the addition of four new medical experts to its nephrology medical leadership team. With the addition of these highly-qualified physicians,…
[On-Demand] High Yield Considerations for Clinical Development in Rare and Genetic Diseases of the Kidney
Senior Medical Director Ajay Srivastava discusses high yield considerations for clinical development in rare genetic diseases of the kidney.
Chronic Kidney Disease & Its Impact on Clinical Development – Part 2
This post is the second of a three-part blog series. In Part 2, we take a look at the biomarkers for chronic kidney disease.
Chronic Kidney Disease & Its Impact on Clinical Development – Part 1
Recently, medical and operational experts from our nephrology team presented a webinar on Chronic Kidney Disease (CKD). Over the next several weeks, we will build…
Webinar: How A Deeper Understanding of Chronic Kidney Disease Is Impacting Clinical Development
Medpace’s experts will be discussing important topics from both a medical and operational perspective.